» Articles » PMID: 15586324

A New Susceptibility Locus for Migraine with Aura in the 15q11-q13 Genomic Region Containing Three GABA-A Receptor Genes

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 2004 Dec 9
PMID 15586324
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Migraine is the most common type of chronic episodic headache. Several population-based family studies have suggested a strong genetic predisposition to migraine, especially migraine with aura (MA). Although several susceptibility loci have been identified, none of the numerous studies performed to date have led to the identification of a gene responsible for the more common forms of migraine. GABA-A receptors and their modulator sites seem to be involved in the pathophysiological events that underlie migraine. We report on clinical and molecular data from a total of 10 families with MA, in which MA segregates as an autosomal dominant trait and presents with homogeneous clinical features. After excluding linkage with the known candidate loci, we used a functional candidate approach and genotyped these families with markers from the 15q11-q13 genomic region, which contains the genes encoding GABA-A receptor subunits. Evidence of linkage was obtained with a parametric two-point linkage analysis (maximum LOD score of 5.56 at a recombination fraction of 0.001 for marker GABRB3) and was supported by multipoint analysis (maximum LOD score of 6.54 between markers D15S113 and D15S1019). The critical region spanned 3.6 Mb. These results provide the basis for further investigation of the hypothesized relationship between a GABA-A receptor dysfunction and migraine.

Citing Articles

The Dawn and Advancement of the Knowledge of the Genetics of Migraine.

Zalaquett N, Salameh E, Kim J, Ghanbarian E, Tawk K, Abouzari M J Clin Med. 2024; 13(9).

PMID: 38731230 PMC: 11084801. DOI: 10.3390/jcm13092701.


Molecular and Cellular Neurobiology of Circadian and Circannual Rhythms in Migraine: A Narrative Review.

Imai N Int J Mol Sci. 2023; 24(12).

PMID: 37373239 PMC: 10298320. DOI: 10.3390/ijms241210092.


Role of Omics in Migraine Research and Management: A Narrative Review.

Chaturvedi P, Khan R, Sahu P, Ludhiadch A, Singh G, Munshi A Mol Neurobiol. 2022; 59(9):5809-5834.

PMID: 35796901 DOI: 10.1007/s12035-022-02930-3.


Continuous and intermittent theta burst stimulation to the visual cortex do not alter GABA and glutamate concentrations measured by magnetic resonance spectroscopy.

Stoby K, Rafique S, Oeltzschner G, Steeves J Brain Behav. 2022; 12(2):e2478.

PMID: 35029058 PMC: 8865152. DOI: 10.1002/brb3.2478.


A review of migraine genetics: gathering genomic and transcriptomic factors.

Dias A, Mariz T, Sousa A, Lemos C, Alves-Ferreira M Hum Genet. 2021; 141(1):1-14.

PMID: 34686893 DOI: 10.1007/s00439-021-02389-7.


References
1.
Wessman M, Kallela M, Kaunisto M, Marttila P, Sobel E, Hartiala J . A susceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet. 2002; 70(3):652-62. PMC: 384944. DOI: 10.1086/339078. View

2.
Bolay H, Reuter U, Dunn A, Huang Z, Boas D, Moskowitz M . Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002; 8(2):136-42. DOI: 10.1038/nm0202-136. View

3.
Pietrobon D, Striessnig J . Neurobiology of migraine. Nat Rev Neurosci. 2003; 4(5):386-98. DOI: 10.1038/nrn1102. View

4.
. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004; 24 Suppl 1:9-160. DOI: 10.1111/j.1468-2982.2003.00824.x. View

5.
Storer R, Akerman S, Shields K, Goadsby P . GABAA receptor modulation of trigeminovascular nociceptive neurotransmission by midazolam is antagonized by flumazenil. Brain Res. 2004; 1013(2):188-93. DOI: 10.1016/j.brainres.2004.03.068. View